Navigation Links
Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
Date:8/25/2013

reated, and we look forward to rewarding our stockholders with an immediate and attractive premium."

Bradway concluded, "Our two companies share a strong culture of innovation and a focus on patient needs. I look forward to bringing the talented people of Onyx and Amgen together as we continue to fulfill our commitment to unlocking the potential of biology for patients suffering from serious illnesses."  

Benefits of the TransactionExcellent Strategic Fit:  Amgen's strategy is to advance innovative medicines that address serious unmet medical needs.   

  • Amgen is a global leader in oncology. As a focused oncology company, Onyx's products and pipeline strengthen Amgen's leading position in this field.
  • Onyx's oncology pipeline adds to Amgen's existing pipeline that addresses areas of serious unmet medical need. Amgen's current pipeline includes nine products for which registration-enabling data are anticipated by 2016.
  • The acquisition of Onyx enables Amgen to continue building its position in international markets, capitalizing on its worldwide commercial, development and manufacturing capabilities. Onyx has global rights to Kyprolis (excluding Japan) and has clinical trials underway supporting an expected European Union (EU) filing in 2014.
  • Amgen's track record in quality and reliability of supply and efficiency in manufacturing will bring an added source of value to the Onyx portfolio.
  • The transaction is expected to deliver meaningful revenue growth and return on capital and to be accretive to adjusted net income in 2015. This will support Amgen's commitment to continue to meaningfully increase its dividend over time.
  • Positions Amgen to Address Growing Patient Needs in Multiple Myeloma

  • Kyprolis is at an early stage of its launch, with global rights, excluding Japan, held by Onyx.  It has an orphan drug designat
    '/>"/>

  • SOURCE Amgen
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

    Related medicine technology :

    1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
    2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
    3. Amgen to Present at the Baird Growth Stock Conference
    4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
    5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
    7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
    8. Amgen Completes Acquisition of KAI Pharmaceuticals
    9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
    10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
    11. Amgen To Present At The Baird Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/27/2015)... -- QT Vascular Ltd., together with its subsidiaries ("QT Vascular" ... design, assembly and distribution of advanced therapeutic solutions for ... into an agreement with a group of investors (the ... This funding will strengthen the Group,s working capital which ... Dr. Eitan Konstantino , Ph.D., ...
    (Date:7/27/2015)... York , July 27, 2015 ... Research "Bionics Market - Global Industry Analysis, Size, Share, Growth, ... valued at USD 7.96 billion in 2014, growing at a ... USD 20.49 billion in 2021. The global bionics ... number of accidents, which is leading to paralysis or amputation ...
    (Date:7/27/2015)... , July 27, 2015 Dynatronics Corporation (NASDAQ: DYNT ... Solaris therapeutic modality products. This approval allows the company to sell ... countries around the world. "Receiving the CE Mark represents ... stated Kelvyn H. Cullimore Jr. , president and CEO of ... network into China , Japan ...
    Breaking Medicine Technology:QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Dynatronics Awarded CE Mark Approval for Its Solaris Products 2
    ... trauma or,noise-induced hearing loss. By any name, it,s the ... 28 million Americans,have impaired hearing; for as many as ... December 2007 issue of Harvard Men,s,Health Watch., Acoustic ... exposure,is the most common cause, but recreational noise -- ...
    ... Proven to Significantly Improve Overall Survival in ... Patients ... 19 ,Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq:,ONXX) today ... a supplemental New Drug Application for Nexavar(R) (sorafenib),tablets for the ...
    Cached Medicine Technology:Your Hearing May be at Risk, Says Harvard Men's Health Watch 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 3Nexavar First FDA-Approved Drug Therapy for Liver Cancer 4Nexavar First FDA-Approved Drug Therapy for Liver Cancer 5Nexavar First FDA-Approved Drug Therapy for Liver Cancer 6
    (Date:7/27/2015)... ... 27, 2015 , ... With a new charity program in the Chico, CA ... of reducing the number of deaths and injuries occurring from police pursuits, and announced ... PursuitSAFETY works with the police to find better and safer ways to conduct pursuits. ...
    (Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they know ... tooth loss can incur a lot of stress, pain, discomfort and embarrassment, which is ... The All-On-4™ treatment reaps the benefits of implants with the cost savings of dentures ...
    (Date:7/27/2015)... ... July 27, 2015 , ... In a creative effort to ... restore a healthy lifestyle, The Ranch at Dove Tree in Lubbock has shared a ... easily through the steps of recovery. Both the nationally recognized collegiate program and traditional ...
    (Date:7/27/2015)... ... ... SupplyLogic, a marketing execution partner based in metro New York and Chicago ... blog, Founder and CEO Kevin Sherlock discusses the value in supply chain visibility by ... is it the closer you get to the ocean, the more seafood costs?’ Those ...
    (Date:7/27/2015)... ... 27, 2015 , ... The Tedesco Agency, a locally owned ... a joint charity effort with non-profit Iraq and Afghanistan Veterans of America, an ... returning from overseas. , The mission of Iraq and Afghanistan Veterans of America ...
    Breaking Medicine News(10 mins):Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 2Health News:Gary Short & Associates in Chico, CA Initiates Charity Campaign to Collaborate with National Nonprofit PursuitSAFETY 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 3Health News:SupplyLogic Releases First Executive Blog on Supply Chain Management Issues 2Health News:The Tedesco Agency of North Dallas and Non-Profit IAVA Announce Joint Charity Effort to Support American Veterans 2
    ... failure patients and for the first time researchers have ... improve heart failure outcomes, a highlight of the recent ... self-care was the need to establish the mechanisms by ... Christopher S. Lee, PhD, RN of the ...
    ... People with HIV are at increased risk for blood vessel ... if these patients are more likely to suffer a serious ... Heart Association revealed that the risk for heart attack among ... "stress echoes" is 10 times greater than in the general ...
    ... , WEDNESDAY, July 13 (HealthDay News) -- Wearing flip-flops ... an expert warns. "Most skin cancers occur on the ... sun," Dr. Rebecca Tung, director of the dermatology division at ... Loyola news release. "The problem with flip-flops and baseball ...
    ... from the University of California, Irvine, with assistance from ... have found a new approach to the creation of ... antiviral drugs. The findings, published online this week ... new drugs that exploit so-called flu protein ,pockets., ...
    ... July 13 (HealthDay News) -- People with autism and ... in an area of the brain associated with empathy, ... ,biomarker, for a familial risk for autism could help ... study suggests. "The findings provide a springboard ...
    ... an evening news program without hearing about an out-of-control ... how safe and comfortable is the clothing ... fires? Researchers at North Carolina State University are working ... gear worn by wildland firefighters to protect against ...
    Cached Medicine News:Health News:Heart failure: Doing what your doctor says works 2Health News:Ultrasound May Determine Heart Attack Risk in HIV Patients 2Health News:Flip-Flops, Baseball Caps May Raise Risk of Skin Cancer 2Health News:UC Irvine study points to new approach to influenza's antiviral resistance 2Health News:Low 'Empathy' Response in Brain Might Point to Autism Gene 2Health News:Research hopes to improve suits for fighting wildfires 2
    ... Richmond Products includes the four demonstration plates, the ... for a total of 24 plates. Each of ... and clean page selection. The test also includes ... laminated copy of the score sheet. The score ...
    ... charts are recognized internationally as a ... deficiency. With normal color perception, the ... visible. Each color test plate in ... printed to measure incrementally higher color ...
    Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
    Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
    Medicine Products: